Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.

Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.

Item
http://www.wikidata.org/entity/Q31019029
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study.Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status.Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort.Adiponectin provides additional information to conventional cardiovascular risk factors for assessing the risk of atherosclerosis in both genders.Hormonal and nutritional effects on cardiovascular risk markers in young women.Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging.Is there an estrogenic component in the metabolic syndrome?Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.Sex differences in the relationship between C-reactive protein and body fat.Bioactive compounds with effects on inflammation markers in humans.Postmenopausal hormone therapy and coronary heart disease in early postmenopausal women.Inflammatory Obesity Phenotypes, Gender Effects, and Subclinical Atherosclerosis in African Americans: The Jackson Heart Study.Mechanisms of estrogen protection in diabetes and metabolic disease.Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors.Ovariectomy is protective against renal injury in the high-salt-fed older mRen2. Lewis rat.
P2860

Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.

Item
http://www.wikidata.org/entity/Q31019029
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hormone therapy, C-reactive pr ...... y Atherosclerosis (ERA) trial.
@ast
Hormone therapy, C-reactive pr ...... y Atherosclerosis (ERA) trial.
@en
type
label
Hormone therapy, C-reactive pr ...... y Atherosclerosis (ERA) trial.
@ast
Hormone therapy, C-reactive pr ...... y Atherosclerosis (ERA) trial.
@en
prefLabel
Hormone therapy, C-reactive pr ...... y Atherosclerosis (ERA) trial.
@ast
Hormone therapy, C-reactive pr ...... y Atherosclerosis (ERA) trial.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Hormone therapy, C-reactive pr ...... y Atherosclerosis (ERA) trial.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921